Utilizing 3 faculty experts, this symposium will combine interactive lectures and clinical case vignettes to describe the role of CDK 4/6 inhibitors in breast cancer therapy, while highlighting best practices for delivering quality nursing care to patients taking these agents. With a panel discussion session that will allow for lively interactions between experts and learners, this symposium will also solidify take-home points regarding decisions and interactions with patients in routine daily nursing practice.
Supported in part by an educational grant from Pfizer.
